×
Aclarion EBIT Margin 2021-2025 | ACON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Aclarion ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
Aclarion EBIT Margin 2021-2025 | ACON
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Aclarion ebit margin from 2021 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$150.5B
CVS Health (CVS)
$84.6B
Elevance Health (ELV)
$66.5B
Cencora (COR)
$57.2B
DiDi Global (DIDIY)
$25.8B
Labcorp Holdings (LH)
$22.5B
Natera (NTRA)
$21.7B
BioMerieux (BMXMF)
$17.2B
EUROFINS SCIENT (ERFSF)
$15.5B
ICON (ICLR)
$14.2B
CochLear (CHEOY)
$13B
Medpace Holdings (MEDP)
$12.9B
Solventum (SOLV)
$12.7B
Viatris (VTRS)
$12.5B
Caris Life Sciences,�Inc (CAI)
$10.4B
Revvity (RVTY)
$10.4B
Sonic Healthcare (SKHHY)
$9.2B
Avantor (AVTR)
$8.8B
Charles River Laboratories (CRL)
$7.7B
HealthEquity (HQY)
$7.6B
Bausch + Lomb (BLCO)
$5B
Sotera Health (SHC)
$4.5B
BrightSpring Health Services (BTSG)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.5B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.9B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B
Premier (PINC)
$2B